The agency’s consultation on the post-Brexit regulatory framework for medical devices and diagnostics aims to support innovation and sustainability, among other goals. By Eveline Van Keymeulen, Ranulf Barman, Oliver Mobasser, and Frances Stocks Allen A 10-week consultation launched by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on the future regulation of medical devices, … Continue Reading
